CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 2.56: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.76%
Annual Rate
CNY 1.00Paid semi-annual
Payout Ratio
227.3%High
Payback Period
34.6 yr
Last Ex-Dividend
Jun 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.84BCNY422.28M · vs all stocks (USD)
Revenue (TTM)
641.11MCNY95.22M · vs all stocks (USD)
Profit Margin
-1.84%vs Medical Instruments & Supplies peers
Beta
0.3780xvs all stocks
52-Week Change
10.56%vs all stocks
Forward Annual Dividend Yield
2.76%vs all stocks
Market Capitalization
2.84BCNY422.28M · vs all stocks (USD)
Enterprise Value
3.15BCNY467.60M · vs all stocks (USD)
Forward P/E
10.88xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.50xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.61xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.91xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
25.78xvs Medical Instruments & Supplies peers
Gross Margin
47.93%vs Medical Instruments & Supplies peers
Profit Margin
-1.84%vs Medical Instruments & Supplies peers
Operating Margin
18.59%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.00%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-1.02%vs Medical Instruments & Supplies peers
Revenue (TTM)
641.11MCNY95.22M · vs all stocks (USD)
Revenue per Share (TTM)
7.90CNYUpdated Aug 20, 2026Quarterly Revenue Growth
66.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
283.44MCNY42.10M · vs all stocks (USD)
EBITDA (TTM)
71.45MCNY10.61M · vs all stocks (USD)
Net Income (TTM)
-11.80MCNY-1.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
90.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
91.22MCNY13.55M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-366.79MCNY-54.48M · vs all stocks (USD)
Forward Annual Dividend Rate
1.00CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
2.76%vs all stocks
Trailing Annual Dividend Rate
1.00CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.76%vs all stocks
Payout Ratio
227.27%vs Medical Instruments & Supplies peers
Revenue
575.76MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
328.33MCNYFY2025 · Dec 31, 2025Gross Profit
247.43MCNYFY2025 · Dec 31, 2025Operating Income
48.30MCNY7.17M · vs all stocks (USD)
Pre-tax Income
-10.78MCNYFY2025 · Dec 31, 2025Income Tax Expense
5.44MCNYFY2025 · Dec 31, 2025Net Income
-16.22MCNYFY2025 · Dec 31, 2025EBIT
2.40MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
71.45MCNYFY2025 · Dec 31, 2025Research & Development
56.93MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
53.12MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.05MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.18MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1999CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1999CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
81.12MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
81.12MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-16.22MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00CNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-76.78MCNYFY2025 · Dec 31, 2025Free Cash Flow
-381.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
280.39MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-16.22MCNYFY2025 · Dec 31, 2025Other Non-cash Items
28.48MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-70.97MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.07MCNYFY2025 · Dec 31, 2025Capital Expenditures
-304.80MCNYFY2025 · Dec 31, 2025Net Acquisitions
-106.54MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.18BCNYFY2025 · Dec 31, 2025Sale of Investments
1.32BCNYFY2025 · Dec 31, 2025Other Investing Activity
-63.81MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-341.82MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
461.62MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-181.54MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-41.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.72MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
235.79MCNYFY2025 · Dec 31, 2025Shares Outstanding
82.55MSharesUpdated Aug 20, 2026Float Shares
22.64MSharesUpdated Aug 20, 2026% Held by Insiders
71.41%vs all stocks
% Held by Institutions
5.56%vs all stocks
Total Cash (MRQ)
632.07MCNY93.88M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.67CNYUpdated Aug 20, 2026Total Debt (MRQ)
830.54MCNY123.35M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7450xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.53xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
13.53CNYUpdated Aug 20, 2026Total Assets
2.07BCNY306.92M · vs all stocks (USD)
Total Current Assets
928.95MCNYFY2025 · Dec 31, 2025Total Liabilities
920.15MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.14BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
355.13MCNYFY2025 · Dec 31, 2025Total Current Liabilities
565.03MCNYFY2025 · Dec 31, 2025Cash
417.73MCNYFY2025 · Dec 31, 2025Cash Equivalents
19.13MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
436.86MCNYFY2025 · Dec 31, 2025Other Short-term Investments
155.83MCNYFY2025 · Dec 31, 2025Accounts Receivable
106.87MCNYFY2025 · Dec 31, 2025Inventory
119.26MCNYFY2025 · Dec 31, 2025Accounts Payable
160.65MCNYFY2025 · Dec 31, 2025Short-term Debt
330.32MCNYFY2025 · Dec 31, 2025Other Current Liabilities
10.46MCNYFY2025 · Dec 31, 2025Long-term Debt
332.10MCNYFY2025 · Dec 31, 2025Common Stock (Book)
58.95MCNYFY2025 · Dec 31, 2025Retained Earnings
315.95MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.15BCNY170.26M · vs all stocks (USD)
Treasury Stock
57.66MCNYFY2025 · Dec 31, 202552-Week Low
28.72CNYUpdated Aug 20, 202652-Week High
48.56CNYUpdated Aug 20, 202652-Week Change
10.56%vs all stocks
Beta
0.3780xvs all stocks
50-Day MA
34.58CNYUpdated Aug 20, 2026200-Day MA
38.86CNYUpdated Aug 20, 2026Avg 10-Day Volume
662.86KSharesUpdated Aug 20, 2026Avg 30-Day Volume
829.76KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.1500CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: -0.02
Financial Health
Altman Z-Score 2.56: grey zoneSignificant
Altman Z-Score: 2.56
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Qingdao Guolin Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Blumar S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanxi Yongdong Chemistry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Lianming Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Huayang Intelligence Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Flag Chemical Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Bajaj Electricals Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai W-Ibeda High Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Huiyun Titanium Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lets Holdings Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
YoungTek Electronics Corp.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Fujian Forecam Optics Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Labtech Instrument Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated